Cansford Laboratories Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cansford Laboratories Ltd. - overview
Established
2011
Location
Cardiff, -, UK
Primary Industry
Healthcare
About
Based in Wales, UK, and founded in 2011, Cansford Laboratories Ltd. operates as a test service provider firm that offers drug and alcohol testing services to its clients. The company was founded by John Wicks (CEO) and Lolita Tsanaclis (Chief Scientific Officer). In April 2023, Phenna Group TopCo Limited, a portfolio company of Oakley Capital Private Equity, fully acquired Cansford Laboratories Ltd.
As of 2021, the firm is having more than 50 partners worldwide, 200 organizations, and 5000 individuals. The firm offers various testing services for sectors such as family law, government, workplaces, social care, individuals, etc. It offers a testing laboratory and offers services that include drug and alcohol testing, steroid testing, prescription medication, DNA testing, etc. It also provides Oral fluid testing, Nail testing, Peth blood testing, and hair testing.
Current Investors
Phenna Group Holdings Limited
Primary Industry
Healthcare
Sub Industries
Diagnostic, Medical & Imaging Laboratories
Website
www.cansfordlabs.co.uk
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Cansford Laboratories Ltd. - timeline of key events
Cansford Laboratories Ltd. - financials
| Fiscal Year Ended | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | - | - | - | - | - | 4,961,090 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - | 2,033,567 | - | - | - |
| Operating Income (USD) | - | - | - | - | - | 1,831,641 | - | - | - |
| Operating Margin | - | - | - | - | - | 36.9% | - | - | - |
| % EBITDA Margin | - | - | - | - | - | 41.0% | - | - | - |
| NET Income (USD) | 47,120 | 248,767 | - | - | - | 1,593,648 | - | - | - |
| % Net Margin | - | - | - | - | - | 32.1% | - | - | - |
Cansford Laboratories Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Cansford Laboratories Ltd. | - |
Displaying 1 - 1 of 1
Cansford Laboratories Ltd. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.